ADC Therapeutics SA Current Liabilities
ADC Therapeutics SA (ADCT) had Current Liabilities of $86.33 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $86.33M.
- 2026-03-31: Liabilities, Current $67.63M.
- 2025-12-31: Liabilities, Current $70.16M.
- 2025-09-30: Liabilities, Current $62.04M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $86.33M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $67.63M 10-Q · filed 2026-05-04 |
| 2025-12-31 | $70.16M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $62.04M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $64.60M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $57.79M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $80.47M 10-K · filed 2026-03-10 |
| 2024-09-30 | $67.68M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $57.63M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $62.98M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $67.67M 10-K · filed 2025-03-27 |
| 2022-12-31 | $81.94M 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |